Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels. 2011

Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA. mxia@mail.nih.gov

The human ether-a-go-go-related gene (hERG) channel, a member of a family of voltage-gated potassium (K(+)) channels, plays a critical role in the repolarization of the cardiac action potential. The reduction of hERG channel activity as a result of adverse drug effects or genetic mutations may cause QT interval prolongation and potentially leads to acquired long QT syndrome. Thus, screening for hERG channel activity is important in drug development. Cardiotoxicity associated with the inhibition of hERG channels by environmental chemicals is also a public health concern. To assess the inhibitory effects of environmental chemicals on hERG channel function, we screened the National Toxicology Program (NTP) collection of 1408 compounds by measuring thallium influx into cells through hERG channels. Seventeen compounds with hERG channel inhibition were identified with IC(50) potencies ranging from 0.26 to 22μM. Twelve of these compounds were confirmed as hERG channel blockers in an automated whole cell patch clamp experiment. In addition, we investigated the structure-activity relationship of seven compounds belonging to the quaternary ammonium compound (QAC) series on hERG channel inhibition. Among four active QAC compounds, tetra-n-octylammonium bromide was the most potent with an IC(50) value of 260nM in the thallium influx assay and 80nM in the patch clamp assay. The potency of this class of hERG channel inhibitors appears to depend on the number and length of their aliphatic side-chains surrounding the charged nitrogen. Profiling environmental compound libraries for hERG channel inhibition provides information useful in prioritizing these compounds for cardiotoxicity assessment in vivo.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051638 Ether-A-Go-Go Potassium Channels A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration. ERG Potassium Channels,Eag Potassium Channels,Eag-Related Potassium Channels,Ether-A-Go-Go Related Potassium Channels,Eag Related Potassium Channels,Ether A Go Go Potassium Channels,Ether A Go Go Related Potassium Channels,Potassium Channels, ERG,Potassium Channels, Eag,Potassium Channels, Eag-Related,Potassium Channels, Ether-A-Go-Go
D018408 Patch-Clamp Techniques An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used. Patch Clamp Technique,Patch-Clamp Technic,Patch-Clamp Technique,Voltage-Clamp Technic,Voltage-Clamp Technique,Voltage-Clamp Techniques,Whole-Cell Recording,Patch-Clamp Technics,Voltage-Clamp Technics,Clamp Technique, Patch,Clamp Techniques, Patch,Patch Clamp Technic,Patch Clamp Technics,Patch Clamp Techniques,Recording, Whole-Cell,Recordings, Whole-Cell,Technic, Patch-Clamp,Technic, Voltage-Clamp,Technics, Patch-Clamp,Technics, Voltage-Clamp,Technique, Patch Clamp,Technique, Patch-Clamp,Technique, Voltage-Clamp,Techniques, Patch Clamp,Techniques, Patch-Clamp,Techniques, Voltage-Clamp,Voltage Clamp Technic,Voltage Clamp Technics,Voltage Clamp Technique,Voltage Clamp Techniques,Whole Cell Recording,Whole-Cell Recordings
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
June 2016, Toxicological sciences : an official journal of the Society of Toxicology,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
April 1954, Science (New York, N.Y.),
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
August 1948, Farmacevtisk revy,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
November 1991, The Journal of general physiology,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
August 2002, The Journal of general physiology,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
March 1993, Neuron,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
December 2022, Journal of cleaner production,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
June 1994, Toxicology,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
April 2016, The Journal of antibiotics,
Menghang Xia, and Sampada A Shahane, and Ruili Huang, and Steven A Titus, and Enoch Shum, and Yong Zhao, and Noel Southall, and Wei Zheng, and Kristine L Witt, and Raymond R Tice, and Christopher P Austin
September 1951, Biochimica et biophysica acta,
Copied contents to your clipboard!